DEVELOPMENTAL CENTERS FOR RESEARCH ON COMPLEMENTARY AND ALTERNATIVE MEDICINE
(DCRC)
RELEASE DATE: October 20, 2003
NOTICE: NOT-AT-04-003
National Center for Complementary and Alternative Medicine (NCCAM)
(http://www.nccam.nih.gov/)
LETTER OF INTENT RECEIPT DATES: January 17, 2004; January 15, 2005
APPLICATION RECEIPT DATES: February 17, 2004; February 15, 2005
This Notice is to clarify the requirements of Program Announcement PAR-03-046
(http://grants.nih.gov/grants/guide/pa-files/PAR-03-046.html ), and remind
applicants that preference may be given to applications proposing research on one
of NCCAM’s FY 2004 research priority areas, listed at
http://www.nccam.nih.gov/research/priorities/index.htm. Applications
substantially similar to those DCRC already funded (listed at
http://nccam.nih.gov/training/centers/index.htm) may be given lower program
priority.
FUNDS AVAILABLE
Applications exceeding $600,000 in direct costs in any year will be considered
unresponsive and returned without further consideration. Applicants requesting
$500,000 or more in direct costs are not required to obtain IC agreement to
accept the application.
ELIGIBLE INSTITUTIONS AND LEADERSHIP OF DEVELOPMENTAL CENTERS
Developmental Centers for Research on Complementary and Alternative Medicine may
be directed by a Principal Investigator (P.I.) from an institution devoted to
complementary and alternative medicine (CAM; as defined in PAR-03-046) or
conventional medicine. An important objective of this program is to facilitate
development of the capacity of CAM investigators and CAM institutions to
participate in the CAM research enterprise. Therefore applications in which a
CAM institution is the applicant organization are especially encouraged.
Applications in which the applicant is not a CAM institution will also be
considered responsive but should outline thoroughly the strategy for promoting
the development of the participating CAM organization(s).
STRUCTURAL REQUIREMENTS FOR DEVELOPMENTAL CENTERS
NCCAM does not encourage applications for Centers focused on a particular
population group unless there is a strong scientific rationale for such a focus.
REVIEW CRITERIA FOR INDIVIDUAL RESEARCH PROJECTS
In addition to the review criteria enumerated in PAR-03-046, criteria for
evaluation of clinical research approaches will include the following: Does the
clinical protocol include clear objectives and a trial design and sample size
that adequately address those objectives? Does it contain a clear description
of interventions, of efficacy and safety parameters and endpoints, and of
ethical considerations including monitoring?
LETTER OF INTENT
Applicants are strongly encouraged to submit a letter of intent, as described in
PAR-03-046. The letter of intent should be sent to:
Barbara Sorkin, Ph.D.
Program Officer
Division of Extramural Research and Training
National Center for Complementary and Alternative Medicine
6707 Democracy Boulevard, Suite 401
Bethesda, MD 20892-5475
Phone: 301-496-8004
E-mail: [email protected]
INQUIRIES
Further information about this program is available on the NCCAM website,
http://nccam.nci.nih.gov/training/centers/index.htm#4. If you have additional
questions regarding the DCRC initiative, please contact:
Barbara Sorkin, Ph.D.
Program Officer
Division of Extramural Research and Training
National Center for Complementary and Alternative Medicine
6707 Democracy Boulevard, Suite 401
Bethesda, MD 20892-5475
Phone: 301-496-8004
E-mail: [email protected]
For scientific/programmatic questions regarding the responsiveness of your
proposal to the DCRC initiative, please contact the appropriate NCCAM Program
Officer, listed at http://nccam.nih.gov/research/contact/index.htm.
SUPPLEMENTARY INSTRUCTIONS
Appendix: the appendix (one for the entire application) may include up to five
publications per project and core proposed in the application, consistent with
the PHS 398 instructions. The order of materials in the appendix should follow
that of the application, i.e., starting with materials relevant to the overall
Program, continuing with materials relevant to the individual projects, and
concluding with any materials relevant to the core(s). Every appendix item
pertaining to a specific project or core must be clearly labeled as such.
Please do not staple the appendix. Sections may be separated, for example, by
interpolating sheets of colored paper.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||